6.
Ji Y, Chen S, Yang K, Zhou J, Zhang X, Jiang X
. A prospective multicenter study of sirolimus for complicated vascular anomalies. J Vasc Surg. 2021; 74(5):1673-1681.e3.
DOI: 10.1016/j.jvs.2021.04.071.
View
7.
Schwartz R, Dabski C, DABSKA M
. The Dabska tumor: a thirty-year retrospect. Dermatology. 2000; 201(1):1-5.
DOI: 10.1159/000018419.
View
8.
Li J, Chen C, Liu W, Liu S, Hu W, Gao X
. Whole-exome sequencing in clear cell sarcoma of soft tissue uncovers novel prognostic categorization and drug targets. Clin Transl Med. 2021; 11(12):e640.
PMC: 8684775.
DOI: 10.1002/ctm2.640.
View
9.
Chen S, Deniz K, Sung Y, Zhang L, Dry S, Antonescu C
. Ewing sarcoma with ERG gene rearrangements: A molecular study focusing on the prevalence of FUS-ERG and common pitfalls in detecting EWSR1-ERG fusions by FISH. Genes Chromosomes Cancer. 2015; 55(4):340-9.
PMC: 5006947.
DOI: 10.1002/gcc.22336.
View
10.
Gomes C, Diniz M, de Menezes G, Castro W, Gomez R
. BRAFV600E Mutation in Melanotic Neuroectodermal Tumor of Infancy: Toward Personalized Medicine?. Pediatrics. 2015; 136(1):e267-9.
DOI: 10.1542/peds.2014-3331.
View
11.
Papke Jr D, Al-Ibraheemi A, Fletcher C
. Plexiform Myofibroblastoma: Clinicopathologic Analysis of 36 Cases of a Distinctive Benign Tumor of Soft Tissue Affecting Mainly Children and Young Adults. Am J Surg Pathol. 2020; 44(11):1469-1478.
DOI: 10.1097/PAS.0000000000001534.
View
12.
Dekeuleneer V, El Nemnom P, Vervier J, Brichard B, Libert J, Van Eeckhout P
. Primary cutaneous Ewing sarcoma in a young girl. Eur J Dermatol. 2019; .
DOI: 10.1684/ejd.2018.3477.
View
13.
Chicaud M, Frassati-Biaggi A, Kaltenbach S, Karanian M, Orbach D, Fraitag S
. Dermatofibrosarcoma protuberans, fibrosarcomatous variant: A rare tumor in children. Pediatr Dermatol. 2020; 38(1):217-222.
DOI: 10.1111/pde.14393.
View
14.
Requena L, Santonja C, Martinez-Amo J, Saus C, Kutzner H
. Cutaneous epithelioid sarcomalike (pseudomyogenic) hemangioendothelioma: a little-known low-grade cutaneous vascular neoplasm. JAMA Dermatol. 2013; 149(4):459-65.
DOI: 10.1001/jamadermatol.2013.3190.
View
15.
Raftopoulos E, Royer M, Warren M, Zhao J, Rush W
. Pseudomyogenic Hemangioendothelioma: Case Report and Review of the Literature. Am J Dermatopathol. 2018; 40(8):597-601.
DOI: 10.1097/DAD.0000000000001104.
View
16.
Sirvent N, Maire G, Pedeutour F
. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer. 2003; 37(1):1-19.
DOI: 10.1002/gcc.10202.
View
17.
Jamshidi F, Bashashati A, Shumansky K, Dickson B, Gokgoz N, Wunder J
. The genomic landscape of epithelioid sarcoma cell lines and tumours. J Pathol. 2015; 238(1):63-73.
DOI: 10.1002/path.4636.
View
18.
Laetsch T, Dubois S, Mascarenhas L, Turpin B, Federman N, Albert C
. Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study. Lancet Oncol. 2018; 19(5):705-714.
PMC: 5949072.
DOI: 10.1016/S1470-2045(18)30119-0.
View
19.
Wegert J, Vokuhl C, Collord G, Del Castillo Velasco-Herrera M, Farndon S, Guzzo C
. Recurrent intragenic rearrangements of EGFR and BRAF in soft tissue tumors of infants. Nat Commun. 2018; 9(1):2378.
PMC: 6006309.
DOI: 10.1038/s41467-018-04650-6.
View
20.
Ryu Y, Choi Y, Cheon J, Kim W, Kim I, Park J
. Imaging findings of Kaposiform Hemangioendothelioma in children. Eur J Radiol. 2016; 86:198-205.
DOI: 10.1016/j.ejrad.2016.11.015.
View